---
title: A three-year experience with the balloon expandable GORE® VIABAHN® VBX in the
  treatment of thoraco-abdominal aortic aneurysms within the EXPAND Trial
date: '2024-10-10'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39389214/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241011200432&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: The VBX stent demonstrated excellent sustained results
  at three years with almost 94% primary patency, 97% secondary patency, and 94.5%
  freedom from target vessel instability. Patency in the renal arteries was lower
  than in the celiac trunk and SMA. The VBX stent appears to be a reliable bridging
  stent for target vessels in ...'
disable_comments: true
---
CONCLUSIONS: The VBX stent demonstrated excellent sustained results at three years with almost 94% primary patency, 97% secondary patency, and 94.5% freedom from target vessel instability. Patency in the renal arteries was lower than in the celiac trunk and SMA. The VBX stent appears to be a reliable bridging stent for target vessels in ...